Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo

References

• Bani-Hani AH, Leslie JA, Asanuma H, Dinarello CA, Campbell MT, Meldrum DR, Zhang H, Hile K, Meldrum KK. 2009. IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int. 76:500–511.
   PubMed Web of Science ®Google Scholar
• Boor P, Ostendorf T, Floege J. 2010. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol. 6:643–656.
   PubMed Web of Science ®Google Scholar
• Carew RM, Wang B, Kantharidis P. 2012. The role of EMT in renal fibrosis. Cell Tissue Res. 347:103–116.
   PubMed Web of Science ®Google Scholar
• Chevalier RL, Forbes MS, Thornhill BA. 2009. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75:1145–1152.
   PubMed Web of Science ®Google Scholar
• Ding H, Zhou D, Hao S, Zhou L, He W, Nie J, Hou FF, Liu Y. 2012. Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol: Jasn. 23:801–813.
   PubMed Web of Science ®Google Scholar
• Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. 1999. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 56:1455–1467.
   PubMed Web of Science ®Google Scholar
• Hertig A, Anglicheau D, Verine J, Pallet N, Touzot M, Ancel PY, Mesnard L, Brousse N, Baugey E, Glotz D, et al. 2008. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol. 19:1584–1591.
   PubMed Web of Science ®Google Scholar
• Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 110:341–350.
   PubMed Web of Science ®Google Scholar
• Jiang L, Xu L, Mao J, Li J, Fang L, Zhou Y, Liu W, He W, Zhao AZ, Yang J, et al. 2013. Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. J Am Soc Nephrol: Jasn. 24:1114–1126.
   PubMed Web of Science ®Google Scholar
• Jin YR, Jin JL, Li CH, Piao XX, Jin NG. 2012. Ursolic acid enhances mouse liver regeneration after partial hepatectomy. Pharm Biol. 50:523–528.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Neilson EG. 2003. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 112:1776–1784.
   PubMed Web of Science ®Google Scholar
• Lan HY. 2011. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067.
   PubMed Web of Science ®Google Scholar
• Lange-Sperandio B, Trautmann A, Eickelberg O, Jayachandran A, Oberle S, Schmidutz F, Rodenbeck B, Homme M, Horuk R, Schaefer F. 2007. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol. 171:861–871.
   PubMed Web of Science ®Google Scholar
• Liu Y. 2010. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol: Jasn. 21:212–222.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
   PubMed Web of Science ®Google Scholar
• Murakami S, Takashima H, Sato-Watanabe M, Chonan S, Yamamoto K, Saitoh M, Saito S, Yoshimura H, Sugawara K, Yang J, et al. 2004. Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1. FEBS Lett. 566:55–59.
   PubMed Web of Science ®Google Scholar
• Naber HP, Drabsch Y, Snaar-Jagalska BE, ten Dijke P, van Laar T. 2013. Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion. Biochem Biophy Res Commun. 435:58–63.
   PubMed Web of Science ®Google Scholar
• Pai PG, Chamari Nawarathna S, Kulkarni A, Habeeba U, Reddy CS, Teerthanath S, Shenoy JP. 2012. Nephroprotective effect of ursolic acid in a murine model of gentamicin-induced renal damage. ISRN Pharmacol. 2012:1.
   Google Scholar
• Piera-Velazquez S, Li Z, Jimenez SA. 2011. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol. 179:1074–1080.
   PubMed Web of Science ®Google Scholar
• Rowe RG, Lin Y, Shimizu-Hirota R, Hanada S, Neilson EG, Greenson JK, Weiss SJ. 2011. Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol. 31:2392–2403.
   PubMed Web of Science ®Google Scholar
• Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, Johnson RJ, Kang DH. 2013. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal. 304:F471–F480.
   PubMed Web of Science ®Google Scholar
• Seva Pessoa B, van der Lubbe N, Verdonk K, Roks AJ, Hoorn EJ, Danser AH. 2013. Key developments in renin-angiotensin-aldosterone system inhibition. Nat Rev Nephrol. 9:26–36.
   PubMed Web of Science ®Google Scholar
• Shyu MH, Kao TC, Yen GC. 2008. Hsian-tsao (Mesona procumbens Heml.) prevents against rat liver fibrosis induced by CCl4 via inhibition of hepatic stellate cells activation. Food Chem Toxicol. 46:3707–3713.
   PubMed Web of Science ®Google Scholar
• Sultana N. 2011. Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J Enzyme Inhibit Med Chem. 26:616–642.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890.
   PubMed Web of Science ®Google Scholar
• Wang X, Ikejima K, Kon K, Arai K, Aoyama T, Okumura K, Abe W, Sato N, Watanabe S. 2011. Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells. J Hepatol. 55:379–387.
   PubMed Web of Science ®Google Scholar
• Wolf G, Ritz E. 2005. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int. 67:799–812.
   PubMed Web of Science ®Google Scholar
• Wu C-F, Chiang W-C, Lai C-F, Chang F-C, Chen Y-T, Chou Y-H, Wu T-H, Linn GR, Ling H, Wu K-D, et al. 2013. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Am J Pathol. 182:118–131.
   PubMed Web of Science ®Google Scholar
• Xu-Dubois YC, Galichon P, Brocheriou I, Baugey E, Morichon R, Jouanneau C, Ouali N, Rondeau E, Hertig A. 2014. Expression of the transcriptional regulator snail1 in kidney transplants displaying epithelial-to-mesenchymal transition features. Nephrol Dial Transplant. 29:2136–2144.
   PubMed Web of Science ®Google Scholar
• Yang F, Huang XR, Chung AC, Hou CC, Lai KN, Lan HY. 2010. Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. J Pathol. 221:390–401.
   PubMed Web of Science ®Google Scholar
• Yoshino J, Monkawa T, Tsuji M, Inukai M, Itoh H, Hayashi M. 2007. Snail1 is involved in the renal epithelial-mesenchymal transition. Biochem Biophys Res Commun. 362:63–68.
   PubMed Web of Science ®Google Scholar
• Zhou D, Tan RJ, Zhou L, Li Y, Liu Y. 2013. Kidney tubular β-catenin signaling controls interstitial fibroblast fate via epithelial-mesenchymal communication. Sci Rep. 3:1878.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li JS, Zhang X, Wu YJ, Huang K, Zheng L. 2010. Ursolic acid inhibits early lesions of diabetic nephropathy. Int J Mol Med. 26:565–570.
   PubMed Web of Science ®Google Scholar